Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri

SÜLLÜ, Yüksel

Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri

Yüksel SÜLLÜ (Yüksel SÜLLÜ* * Profesör Doktor, Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, Samsun)

Güncel Retina Dergisi

2 0

Yıl: 2017 Cilt: 1 Sayı: 2 Sayfa Aralığı: 100 - 104 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri

Öz:

Yaşa bağlı maküla dejenerasyonu (YBMD), yaşlı popülasyonda ciddi görme kaybının en başta gelen nedenlerindendir. YBMD multifaktöriyel kompleks bir hastalık olup etiyopatogenezinde birçok çevresel ve genetik risk faktörü rol oynar. Son yıllarda, YBMD patogenezinde rol oynayan birçok genetik varyant saptanmıştır. Bu çalışmada YBMD patogenezinde rol oynadığı bildirilmiş olan çevresel ve genetik risk faktörleri özetlenmiştir

Anahtar Kelime:

Konular: Cerrahi

Genetic and Risk factors in Dry-Form (Non-Neovascular) Age Related Macular Degeneration

Öz:

Age-related macular degeneration (AMD) is the leading cause of severe visual impairment in older persons. AMD is a multifactorial complex disease that both genetic and many environmental factors play roles its etiopathogenesis. In recent years, advances in genetic studies have led to the detection of many genetic variants that play a role in the pathogenesis of AMD. This review summarized environmental and genetic risk factors of AMD

Anahtar Kelime:

Konular: Cerrahi

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik

1. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration pooled findings from three continents. Ophthalmoogy 2001; 108(4): 697-704.
2. Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, et al. Risk factors and biomarkers of age-related macular degeneration. Prog in Retinal and Eye Research 2016 Sep; 54:64-102.
3. Age-Related Eye Disease Study Research Group. Risk factors associated with eye related macular degeneration. A case control study in the age related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 2000; 107(12):2224-2232.
4. Klein R, Klein BEK, Jensen SC, Meuer SM. Five year incidence and progressin of age-related maculopathy. Ophthalmology 1997; 1(1)04:7-21.
5. Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsh JM. Racial differences in the prevalance of age-related macular degeneration: The Baltimore Eye Survey. Opthalmology 1999; 106(6):1049-1055.
6. Hammond BR, Ciulla TA, Snodderly DM. Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 2002; 43(1):47-50.
7. Nolan J, O’Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, et al. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 2004; 45(11):3940-3950.
8. Khan JC, Shahid H, Thuriby DA, Brdaley M, Clayton DG, Moore AT et al. Genetic Factors in AMD Study. Age related macular degeneration and sun exposure, iris color and skin sensitivity to sunlight. Br J Ophthalmol 2006; 90(1):29-32.
9. Age-Related Eye Disease Study 2 Research Group, Chew EY, Clemonts TE, SanGioyanni JP, Danis RP, Ferris FL, et al. Secondary analyses of the effects of lutein/zeaxantin on age-related macular degeneration progression: AREDS2 report No.3. JAMA Opthalmol 2014; 132(2):142-149.
10. Sperduto R, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol 1986; 104(2):216-219.
11. Evans JR, Risk factors for age-related macular degeneration. Progr Retina Eye Res 2001; 20(2):227-253.
12. Klein R, Klein BE, Jensen SC, Cruickshanks KJ. The relationship of ocular factors to the incidence and progression of age-related maculopathy. Arch Ophthalmol 1998; 116(4):506-513.
13. Meyers SM, Greene T, Gutman FA. The twin study on age-related macular degeneration. Am J Ophthalmol 1995; 120(6):757-766.
14. Shahid H, Khan JC, Cipriani V, Sepp T, Matharu BK, Brunce C, Harding SP, Clayton DG, Moore AT, Yates JR, Genetic Factors in AMDSG. Age-related macular degeneration: the importance of family history as a risk factor. Br J Ophthalmol 2012; 96(3):427-431.
15. Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlation and segregation analysis of age-related maculopathy. The Beaver Dam Eye Study. Genet Epidemiol 1994; 11(1):51-67.
16. Klein R, Rowland ML, Harris MI. Radical/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology 1995; 102(8):371-381.
17. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT et al. Genetic risk of age-related maculopathy. Population based familial aggregation study. Arch Ophthalmol 1998; 116(12):1646-1651.
18. Sparrow JR, Parish CA, Hashimoto M, Nakanishi K. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999; 40(12):2988- 2995.
19. Lakkaraju A, Finnemann SC, Rodriguez-Boulan E, The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells. Proc Natl Acad Sci USA 2007; 104(26):11026-11031.
20. Fritche LG, Fleckenstein M, Fiebig BS, Schmitz-Valckenberg S, Bindewald-Wittich A, Keilhauer CN, et al. A subgrup of age-related macular degeneration is associated with monoallelic sequence variants in the ABCA4 gene. Invest Ophthalmol Vis Sci 2012; 53(4):2112-2118.
21. Edwards AO, Ritter 3rd R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308(5720):421-424.
22. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age related macular degeneration. Science 2005; 308(5720):385-389.
23. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complemant factor H variant increases the risk of age-related macular degeneration. Science 2005; 308(5720):419-421.
24. Wang G, Spencer KL, Court BL, Olson LM, Scott WK, Haines JL, Pericak-Vance MA. Localization of age-related macular degeneration-associated ARMS2 in cytosol, not mitochondria. Invest Ophthalmol Vis Sci 2009; 50(7):3084-3090.
25. Klein R, Myers CE, Meuer SM, Gangnon RE, Siyakumaran TA, Ivengar SK, et al. Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol 2013; 131(3):383-392.
26. Holliday EG, Smith AV, Cornes BK, Buitendiik GH, Jensen RA, Sim X, Aspelund T, et al. Insights into the genetic architecture of early stage age-related macular degeneration: a genoma–wide association study meta-analysis. Plos One 2013; 8(1):53830.
27. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314(5801):992-993.
28. Zhang Y, Marmorstein LY. Focus on molecules: fibulin-3 (EFEMP1). Exp Eye Res 2010; 90(3):374-375.
29. Schneider R, Jensen SA, Whiteman P, McCullagh JS, Redfield C, Handford PA. Biophysical characterisation of fibulin-5 proteins associated with disease. J Mol Biol 2010; 401(4):605- 617.
30. Schultz DW, Klein ML, Humpert AJ, Luzier CW, Persun V, Schain M, et al. Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet 2003; 12(24):3315-3323.
31. Galan A, Ferlin A, Caretti L, Buson G, Sato G, Frigo AC, Fooresta C. Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor. Ophthalmology 2010; 117(9):1769-1774.
32. Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27(4):331-371.
33. Kamei M, Hollyfield JG. TIMP-3 in Bruch’s membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999; 40(10):2367-2375.
34. Wang YF, Han Y, Zhang R, Qin L, Wang MX, Ma L. CETP/ LPL/LIPC gene polymorphisms and susceptibility to age related macular degeneration. Sci Rep 2015 Oct 27; 5:15711.
35. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The epsilon2 and epsilon 4 alleles od the apolipoprotein gene are associated with age-ralated macular degeneration. Invest Ophthalmol Vis Sci 2004; 45(5):1311-1315.
36. Chen W, Stambolian D, Edwards AO, Branham KE, Otham M, Jakobsdottir J, Tosakulwong N, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci USA 2010; 107(16):7401-7406.
37. Kondo N, Honda S, Kuno S, Negri A. Role of RDBP and SKIV2L variants in the major histocompatibility complex class III region in polypoidal choroidal vasculopathy etiology. Ophthalmology 2009; 116(8):1502-1509.

APA	SÜLLÜ Y (2017). Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. , 100 - 104.
Chicago	SÜLLÜ Yüksel Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. (2017): 100 - 104.
MLA	SÜLLÜ Yüksel Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. , 2017, ss.100 - 104.
AMA	SÜLLÜ Y Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. . 2017; 100 - 104.
Vancouver	SÜLLÜ Y Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. . 2017; 100 - 104.
IEEE	SÜLLÜ Y "Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri." , ss.100 - 104, 2017.
ISNAD	SÜLLÜ, Yüksel. "Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri". (2017), 100-104.

APA	SÜLLÜ Y (2017). Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. Güncel Retina Dergisi, 1(2), 100 - 104.
Chicago	SÜLLÜ Yüksel Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. Güncel Retina Dergisi 1, no.2 (2017): 100 - 104.
MLA	SÜLLÜ Yüksel Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. Güncel Retina Dergisi, vol.1, no.2, 2017, ss.100 - 104.
AMA	SÜLLÜ Y Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. Güncel Retina Dergisi. 2017; 1(2): 100 - 104.
Vancouver	SÜLLÜ Y Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri. Güncel Retina Dergisi. 2017; 1(2): 100 - 104.
IEEE	SÜLLÜ Y "Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri." Güncel Retina Dergisi, 1, ss.100 - 104, 2017.
ISNAD	SÜLLÜ, Yüksel. "Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Genetik ve Risk Faktörleri". Güncel Retina Dergisi 1/2 (2017), 100-104.